Accessibility Menu
GSK logo

GSK

(NYSE) GSK

Current Price$52.50
Market Cap$105.20B
Since IPO (2000)+188%
5 Year+58%
1 Year+41%
1 Month+2%

GSK Financials at a Glance

Market Cap

$105.20B

Revenue (TTM)

£32.78B

Net Income (TTM)

£5.83B

EPS (TTM)

$3.82

P/E Ratio

13.54

Dividend

$1.80

Beta (Volatility)

0.25 (Low)

Price

$52.50

Volume

197,485

Open

$51.63

Previous Close

$52.50

Daily Range

$51.60 - $52.71

52-Week Range

$35.45 - $61.70

Estimated Earnings Date

Jul 28, 2026

GSK: Motley Fool Moneyball Superscore

76

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GSK

Industry

Pharmaceuticals

Employees

66,841

CEO

Luke Miels, MBA

Headquarters

Brentford, TW8 9GS, GB

GSK Financials

Key Financial Metrics (TTM)

Gross Margin

72.74%

Operating Margin

22.34%

Net Income Margin

17.78%

Return on Equity

35.78%

Return on Capital

24.50%

Return on Assets

9.27%

Earnings Yield

7.39%

Dividend Yield

3.43%

Payout Ratio

44.52%

Stock Overview

Market Cap

$105.20B

Shares Outstanding

2.00B

Volume

197.49K

Avg. Volume

3.94M

Financials (TTM)

Gross Profit

£23.83B

Operating Income

£8.42B

EBITDA

£11.27B

Operating Cash Flow

£8.30B

Capital Expenditure

-£2.06B

Free Cash Flow

£6.24B

Cash & ST Invst.

£4.54B

Total Debt

£25.13B

GSK Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

£7.63B

+1.5%

Gross Profit

£5.75B

+3.1%

Gross Margin

75.42%

N/A

Market Cap

$105.20B

N/A

Market Cap/Employee

$1.53M

N/A

Employees

68,629

N/A

Net Income

£1.74B

+7.0%

EBITDA

£2.77B

-10.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

£4.54B

-21.6%

Total Debt

£25.13B

+5.6%

Accounts Receivable

£10.47B

+8.1%

Inventory

£8.12B

+4.8%

Long Term Debt

£18.48B

-13.1%

Short Term Debt

£6.65B

+163.2%

Return on Assets

9.27%

N/A

Return on Invested Capital

18.11%

N/A

Free Cash Flow

£698.00M

+0.1%

Operating Cash Flow

£1.14B

-0.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNYSanofi
$42.95+2.75%
BMYBristol-Myers Squibb Company
$57.52+3.85%
MCKMcKesson Corporation
$763.51-0.04%
HCAHCA Healthcare, Inc.
$391.68+1.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.87+0.02%
ONDSOndas
$7.83+0.02%
KEELKeel Infrastructure
$6.03+0.03%
HLHecla Mining
$15.54+0.03%

Questions About GSK

What is the current price of GSK?

GSK is trading at $52.50 per share.

What is the 52-week range for GSK?

Over the past 52 weeks, GSK has traded between $35.45 and $61.70.

How much debt does GSK have?

As of the most recent reporting period, GSK reported total debt of £25.13B.

How much cash does GSK have on hand?

GSK reported £4.54B in cash and cash equivalents in its most recent financial results.

What is GSK’s dividend yield?

GSK currently has a dividend yield of 3.43%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.